Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 15 June 2007. doi:10.1136/thx.2006.075077
Thorax 2008;63:42-48
Copyright © 2008 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
thx.2006.075077v1
63/1/42    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jennings, L C
Right arrow Articles by Murdoch, D R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jennings, L C
Right arrow Articles by Murdoch, D R

RESPIRATORY INFECTION

Incidence and characteristics of viral community-acquired pneumonia in adults

L C Jennings1,2, T P Anderson1, K A Beynon1, A Chua1, R T R Laing3, A M Werno1,2, S A Young1, S T Chambers2, D R Murdoch1,2

1 Canterbury Health Laboratories, Christchurch, New Zealand
2 Department of Pathology, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand
3 Canterbury Respiratory Research Group, University of Otago, Christchurch, New Zealand

Correspondence to:
Dr L C Jennings, Canterbury Health Laboratories, P O Box 151, Christchurch, New Zealand; lance.jennings{at}cdhb.govt.nz

Background: In adults, viral causes of community-acquired pneumonia (CAP) are poorly characterised. The aims of this study were to characterise the viral aetiology of CAP in adults by using an extensive array of viral diagnostic tests and to compare the characteristics of viral pneumonia with those of pneumococcal pneumonia.

Methods: Adults admitted to Christchurch Hospital over a 1-year period with CAP were included in the study. Microbiological testing methods included blood and sputum cultures, urinary antigen testing for Streptococcus pneumoniae and Legionella pneumophila, antibody detection in paired sera and detection of respiratory viruses in nasopharyngeal swabs by immunofluorescence, culture and PCR.

Results: Of 304 patients with CAP, a viral diagnosis was made in 88 (29%), with rhinoviruses and influenza A being the most common. Two or more pathogens were detected in 49 (16%) patients, 45 of whom had mixed viral and bacterial infections. There were no reliable clinical predictors of viral pneumonia, although several variables were independently associated with some aetiologies. The presence of myalgia was associated with pneumonia caused by any respiratory virus (OR 3.62, 95% CI 1.29 to 10.12) and influenza pneumonia (OR 190.72, 95% CI 3.68 to 9891.91). Mixed rhinovirus/pneumococcal infection was associated with severe disease.

Conclusions: Virus-associated CAP is common in adults. Polymicrobial infections involving bacterial and viral pathogens are frequent and may be associated with severe pneumonia.





This article has been cited by other articles:


Home page
BMJHome page
G Y Shin
What about viral community acquired pneumonias?
BMJ, August 13, 2008; 337(jul01_2): a598 - a598.
[Full Text]


Home page
J. Immunol.Home page
D. K. Meyerholz, M. Edsen-Moore, J. McGill, R. A. Coleman, R. T. Cook, and K. L. Legge
Chronic Alcohol Consumption Increases the Severity of Murine Influenza Virus Infections
J. Immunol., July 1, 2008; 181(1): 641 - 648.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
U Hohenthal, R Vainionpaa, J Nikoskelainen, and P Kotilainen
The role of rhinoviruses and enteroviruses in community acquired pneumonia in adults
Thorax, July 1, 2008; 63(7): 658 - 659.
[Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
W. G. Nichols, A. J. Peck Campbell, and M. Boeckh
Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances
Clin. Microbiol. Rev., April 1, 2008; 21(2): 274 - 290.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & British Thoracic Society